tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Faron Pharmaceuticals Oy (GB:FARN)
LSE:FARN
UK Market
FARN
Faron Pharmaceuticals Oy
Overview
Analyst Forecasts
Dividends
Earnings
Statistics
New
Technical Analysis
Historical Prices
New
Chart
RESEARCH TOOLS
Top Analyst Stocks
Top Smart Score Stocks
Stock Screener
reports

Faron Pharmaceuticals Oy (FARN) Stock News & Sentiment

Compare
32 Followers
Faron Pharmaceuticals Grants 876,000 Share Options to Directors and Personnel
Premium
Company Announcements
Faron Pharmaceuticals Grants 876,000 Share Options to Directors and Personnel
6d ago
Promising Clinical Data and Innovative Mechanism Drive Buy Rating for Faron Pharmaceuticals’ BEXMAB in MDS Treatment
Premium
Ratings
Promising Clinical Data and Innovative Mechanism Drive Buy Rating for Faron Pharmaceuticals’ BEXMAB in MDS Treatment
7d ago
Faron Pharmaceuticals Sees Increased Share Liquidity Following A&B Divestment
Premium
Company Announcements
Faron Pharmaceuticals Sees Increased Share Liquidity Following A&B Divestment
1M ago
Buy Rating for Faron Pharmaceuticals: Promising Phase 2 Results and Strategic Growth Potential
Premium
Ratings
Buy Rating for Faron Pharmaceuticals: Promising Phase 2 Results and Strategic Growth Potential
1M ago
Faron Pharmaceuticals Reports Positive Phase II Trial Results for HR MDS Treatment
Premium
Company Announcements
Faron Pharmaceuticals Reports Positive Phase II Trial Results for HR MDS Treatment
1M ago
Faron Pharmaceuticals Secures EUR 35 Million Convertible Bond Arrangement
Premium
Company Announcements
Faron Pharmaceuticals Secures EUR 35 Million Convertible Bond Arrangement
2M ago
Positive Outlook for Faron Pharmaceuticals: Buy Rating Backed by Promising Developments in Immunotherapy
Premium
Ratings
Positive Outlook for Faron Pharmaceuticals: Buy Rating Backed by Promising Developments in Immunotherapy
2M ago
More GB:FARN News >

FARN News on the Web

H.C. Wainwright Reaffirms Their Buy Rating on Faron Pharmaceuticals Oy (FARN)
TipRanks News
Neutral
Faron secures up to €35mn funding, clears debt ahead of key drug trial milestone
Proactive Investors
Bearish
Faron Pharma hails 'significant milestone' as US FDA grants orphan drug for second indication
Proactive Investors
Neutral
Faron Pharmaceuticals Oy Full Year 2024 Earnings Call Highlights: Financial Gains and ...
Yahoo Finance
Neutral
Faron Pharma results reveal its strong operational progress
Proactive Investors
Bullish
Faron Pharmaceuticals: European orphan status a 'major milestone'
Proactive Investors
Neutral
Faron Pharma raises €12M for Bexmarilimab trials - ICYMI
Proactive Investors
Bullish
Faron Pharma up 10% after oversubscribed fundraiser
Proactive Investors
Neutral

News Score - Last 7 Days

Neutral
GB:FARN
Sector Average
Media Buzz
This Week0 articles
Weekly Average0 articles
News Sentiment
This Week59%
Sector Average56%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is GB:FARN’s Media Buzz Sentiment?
Currently, no data Available
What is GB:FARN’s weekly average amount of articles?
Currently, no data Available
What is GB:FARN’s News Sentiment?
59% of articles about GB:FARN were positive this week, compared to its sector average of 56%.
    Healthcare Stocks that are Trending in the News
    STESteris
    EXELExelixis
    CRWCraneware
    VVOSVivos Therapeutics
    ABSCFAB Science SA
    Showing the stocks with the most bullish news sentiment over the past week

    Become an Expert with TipRanks Premium

    What am I Missing?
    Make informed decisions based on Top Analysts' activity
    Know what industry insiders are buying
    Get actionable alerts from top Wall Street Analysts
    Find out before anyone else which stock is going to shoot up
    Get powerful stock screeners & detailed portfolio analysis
    Subscribe NowSee Plans & Pricing